Posted on 11/12/20
X-COR Therapeutics Closes $2.6M Funding
Alira Health, a leading international healthcare and life sciences advisory firm, congratulates X-COR Therapeutics for closing a $2.6M seed financing
Posted on 11/12/20
Inozyme Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of . . .
Posted on 11/12/20
TCR Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for . . .
Posted on 11/12/20
Akouos Reports Third Quarter 2020 Financial Results and Provides Business Highlights
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Akouos, Inc. (Nasdaq: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with . . .
Posted on 11/12/20
BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
NEW HAVEN, Conn., Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience . . .
Posted on 11/12/20
iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass. and GOSSELIES, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of . . .
Posted on 11/12/20
SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
STAMFORD, Conn., Nov. 12, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 11/12/20
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
Biogen (NASDAQ:BIIB) might be in deep trouble. The biotech's core multiple sclerosis franchise has been hit hard by generic competition this year, and its plan to . . .
Posted on 11/12/20
Moderna's Cancer Vaccine Scores in a Clinical Trial
On Wednesday, Moderna (NASDAQ:MRNA) announced encouraging results from a clinical trial with an experimental cancer vaccine. Treatment with the messenger RNA-based candidate, mRNA-4157, shrank tumors for . . .
Posted on 11/10/20
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced financial results for the third quarter ended . . .
Posted on 11/10/20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today reported financial results . . .
Posted on 11/10/20
Beam Therapeutics Announces Business and Pipeline Progress and Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported pipeline . . .
Posted on 11/10/20
Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene . . .
Posted on 11/10/20
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates
Norwood, MA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 11/10/20
Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass. and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and . . .
Posted on 11/10/20
Arch Raises Approximately $1.1 Million with Convertible Notes
FRAMINGHAM, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), developer of novel self-assembling wound care and biosurgical devices, announces that it has . . .
Posted on 11/10/20
Fulcrum Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically . . .
Posted on 11/10/20
AlloVir Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today reported financial results for the third quarter ended . . .
Posted on 11/10/20
Adagio Therapeutics Raises $80M Series B
Adagio Therapeutics, Inc., a company developing best-in-class antibodies that broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses, today announced the closing of an $80 million . . .
Posted on 11/10/20
Here's Why Vertex Pharmaceuticals Fell 23.4% in October
What happenedShares of Vertex Pharmaceuticals (NASDAQ:VRTX) fell 23.4% in October, according to data from S&P Global Market Intelligence after the biotech discontinued development of a drug . . .
Posted on 11/10/20
3 Reasons CVS Health Is a Top Healthcare Stock to Buy Now
Shares of CVS Health (NYSE:CVS) leaped higher following an encouraging third-quarter earnings report. Signs of endurance through the COVID-19 pandemic inspired a lot of new investors . . .
Posted on 11/10/20
Why Smith & Wesson, Vista Outdoor, and Sturm, Ruger Stocks All Crashed Despite Today's Vaccine News
What happenedPfizer this morning announced that its new coronavirus vaccine is 90% effective at preventing COVID-19. Is this good news?For most stocks, yes. The Dow Jones . . .
Posted on 11/10/20
Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its third quarter 2020 financial results, program progress and corporate updates.“During . . .
Posted on 11/10/20
Cara Therapeutics Reports Third Quarter 2020 Financial Results
STAMFORD, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 11/10/20
Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Highlights
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the third quarter ended . . .
Boston
